NO20004281L - 6,9-disubstituerte 2-[trans-(4-aminocykloheksyl)amino]puriner, farmasoytisk preparat inneholdende disse, og anvendelse derav for fremstilling av et medikament - Google Patents

6,9-disubstituerte 2-[trans-(4-aminocykloheksyl)amino]puriner, farmasoytisk preparat inneholdende disse, og anvendelse derav for fremstilling av et medikament

Info

Publication number
NO20004281L
NO20004281L NO20004281A NO20004281A NO20004281L NO 20004281 L NO20004281 L NO 20004281L NO 20004281 A NO20004281 A NO 20004281A NO 20004281 A NO20004281 A NO 20004281A NO 20004281 L NO20004281 L NO 20004281L
Authority
NO
Norway
Prior art keywords
present
provides
group
alkyl
formula
Prior art date
Application number
NO20004281A
Other languages
English (en)
Norwegian (no)
Other versions
NO20004281D0 (no
Inventor
Jennifer Ann Dumont
Alan Joseph Bitonti
David Roger Borcherding
Harry Randall Munson
Patrick Wai-Kwok Shum
Norton Paul Peet
Original Assignee
Aventis Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Holdings Inc filed Critical Aventis Holdings Inc
Publication of NO20004281D0 publication Critical patent/NO20004281D0/no
Publication of NO20004281L publication Critical patent/NO20004281L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20004281A 1998-02-26 2000-08-25 6,9-disubstituerte 2-[trans-(4-aminocykloheksyl)amino]puriner, farmasoytisk preparat inneholdende disse, og anvendelse derav for fremstilling av et medikament NO20004281L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3238198A 1998-02-26 1998-02-26
PCT/US1999/003451 WO1999043676A2 (fr) 1998-02-26 1999-02-18 2-[trans-(4- aminocyclohexyl) amino]purines 6,9-disubstituees

Publications (2)

Publication Number Publication Date
NO20004281D0 NO20004281D0 (no) 2000-08-25
NO20004281L true NO20004281L (no) 2000-10-18

Family

ID=21864658

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004281A NO20004281L (no) 1998-02-26 2000-08-25 6,9-disubstituerte 2-[trans-(4-aminocykloheksyl)amino]puriner, farmasoytisk preparat inneholdende disse, og anvendelse derav for fremstilling av et medikament

Country Status (31)

Country Link
EP (1) EP1056745B1 (fr)
JP (1) JP2002504553A (fr)
KR (1) KR100568658B1 (fr)
CN (1) CN1128149C (fr)
AP (1) AP1258A (fr)
AR (1) AR019822A1 (fr)
AT (1) ATE269332T1 (fr)
AU (1) AU748178B2 (fr)
BR (1) BR9908325A (fr)
CA (1) CA2320448C (fr)
CZ (1) CZ291604B6 (fr)
DE (1) DE69918062T2 (fr)
DK (1) DK1056745T3 (fr)
EE (1) EE04315B1 (fr)
ES (1) ES2219038T3 (fr)
HK (1) HK1030948A1 (fr)
HU (1) HUP0100931A3 (fr)
IL (2) IL138044A0 (fr)
NO (1) NO20004281L (fr)
NZ (1) NZ506234A (fr)
OA (1) OA11480A (fr)
PL (1) PL344021A1 (fr)
PT (1) PT1056745E (fr)
RU (1) RU2191777C2 (fr)
SI (1) SI1056745T1 (fr)
SK (1) SK12912000A3 (fr)
TR (1) TR200002482T2 (fr)
TW (1) TW541308B (fr)
UA (1) UA62996C2 (fr)
WO (1) WO1999043676A2 (fr)
ZA (1) ZA991548B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6627633B2 (en) 1999-03-17 2003-09-30 Albany Molecular Research, Inc. 6-substituted biaryl purine derivatives as potent cyclin/CDK inhibitors and antiproliferative agents
US6969720B2 (en) 1999-03-17 2005-11-29 Amr Technology, Inc. Biaryl substituted purine derivatives as potent antiproliferative agents
CA2396276A1 (fr) * 2000-01-07 2001-07-12 Universitaire Instelling Antwerpen Derives de purine, procede de preparation et utilisation de ces derniers
YU54202A (sh) 2000-01-18 2006-01-16 Agouron Pharmaceuticals Inc. Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
HN2001000008A (es) 2000-01-21 2003-12-11 Inc Agouron Pharmaceuticals Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
FR2806626B1 (fr) * 2000-03-22 2003-11-28 Centre Nat Rech Scient Utilisation de substances modulatrices de l'expression ou de la fonction d'une proteine impliquee dans le cycle cellulaire pour le traitement ou la prevention des lesions neurales aigues
WO2001079198A1 (fr) 2000-04-18 2001-10-25 Agouron Pharmaceuticals, Inc. Pyrazoles permettant d'inhiber des proteines kinases
WO2002012250A2 (fr) 2000-08-09 2002-02-14 Agouron Pharmaceuticals, Inc. Composes pyrazole-thiazole, compositions pharmaceutiques les contenant, et leurs procedes d'utilisation pour inhiber les kinases cyclino-dependantes
ATE295354T1 (de) 2000-08-18 2005-05-15 Agouron Pharma Heterozyklische-hydroximino-fluorene und ihre verwendung zur inhibierung von proteinkinasen
GB0117075D0 (en) * 2000-10-31 2001-09-05 Aventis Pharm Prod Inc Acyl and sulfonyl derivatives of 6, 9-distributed 2-(trans-1, 4-diaminocyclohexyl)-purines and their use as antiproliferative agents
MXPA03003774A (es) * 2000-10-31 2003-07-28 Aventis Pharm Prod Inc Derivados de acilo y sulfonilo de 2-(trans-1, 4-diaminociclohexil)-purinas 6,9-disubstituidas y sus uso como agentes antiproliferativos.
US6756374B2 (en) 2001-01-22 2004-06-29 Hoffmann-La Roche Inc. Diaminothiazoles having antiproliferative activity
WO2003002565A1 (fr) * 2001-06-27 2003-01-09 Cyclacel Limited Derives de purine 2,6,9-substitues et leur utilisation dans le traitement de maladies proliferantes
US6667311B2 (en) 2001-09-11 2003-12-23 Albany Molecular Research, Inc. Nitrogen substituted biaryl purine derivatives as potent antiproliferative agents
US6812232B2 (en) 2001-09-11 2004-11-02 Amr Technology, Inc. Heterocycle substituted purine derivatives as potent antiproliferative agents
GB0219054D0 (en) 2002-08-15 2002-09-25 Cyclacel Ltd New purine derivatives
GB0219052D0 (en) 2002-08-15 2002-09-25 Cyclacel Ltd New puring derivatives
CN1744887A (zh) * 2003-02-04 2006-03-08 株式会社益力多本社 乳癌耐性蛋白抑制剂
US7211576B2 (en) 2004-04-20 2007-05-01 Hoffmann-La Roche Inc. Diaminothiazoles
SG170819A1 (en) * 2006-03-30 2011-05-30 Ptc Therapeutics Inc Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associated therewith
AU2008307798B2 (en) * 2007-10-05 2013-10-03 Verastem, Inc. Pyrimidine substituted purine derivatives
CN102241646B (zh) * 2010-05-14 2014-04-09 中国人民解放军军事医学科学院毒物药物研究所 己烯酮类化合物及其医药用途
US9493464B2 (en) 2012-02-29 2016-11-15 The Scripps Research Institute Wee1 degradation inhibitors
US9879014B2 (en) 2013-07-12 2018-01-30 Kyoto University Method for screening substance capable of inhibiting abnormal splicing causative of onset or progress of disease
DK3244891T3 (da) 2015-01-16 2022-10-24 Massachusetts Gen Hospital Forbindelser til forbedring af mrna-splejsning
CN107903274A (zh) * 2017-12-28 2018-04-13 窦玉玲 一种胺类化合物及其在抗肿瘤药物中的应用
WO2021016263A1 (fr) * 2019-07-21 2021-01-28 University Of Virginia Patent Foundation Compositions de liaison à la cystéine et leurs procédés d'utilisation
WO2024105159A1 (fr) * 2022-11-16 2024-05-23 University Of Zurich Ligands des lecteurs d'arn m6a

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9301000D0 (en) * 1993-01-20 1993-03-10 Glaxo Group Ltd Chemical compounds
GB9414208D0 (en) * 1994-07-14 1994-08-31 Glaxo Group Ltd Compounds
PT874846E (pt) * 1995-11-01 2003-08-29 Novartis Ag Derivados de purina e processos para a sua preparacao
FR2741881B1 (fr) * 1995-12-01 1999-07-30 Centre Nat Rech Scient Nouveaux derives de purine possedant notamment des prorietes anti-proliferatives et leurs applications biologiques

Also Published As

Publication number Publication date
PT1056745E (pt) 2004-09-30
EE04315B1 (et) 2004-06-15
RU2191777C2 (ru) 2002-10-27
CZ20003106A3 (cs) 2000-12-13
HK1030948A1 (en) 2001-05-25
CZ291604B6 (cs) 2003-04-16
TR200002482T2 (tr) 2002-10-21
AP2000001923A0 (en) 2000-09-30
ATE269332T1 (de) 2004-07-15
JP2002504553A (ja) 2002-02-12
EE200000501A (et) 2002-02-15
SI1056745T1 (en) 2004-12-31
CN1128149C (zh) 2003-11-19
DK1056745T3 (da) 2004-10-25
KR20010041315A (ko) 2001-05-15
IL138044A (en) 2006-04-10
AR019822A1 (es) 2002-03-20
CA2320448C (fr) 2005-02-01
NO20004281D0 (no) 2000-08-25
SK12912000A3 (sk) 2001-08-06
HUP0100931A2 (hu) 2002-04-29
AP1258A (en) 2004-03-15
EP1056745A2 (fr) 2000-12-06
CN1291983A (zh) 2001-04-18
WO1999043676A2 (fr) 1999-09-02
ZA991548B (en) 1999-08-26
EP1056745B1 (fr) 2004-06-16
TW541308B (en) 2003-07-11
PL344021A1 (en) 2001-09-24
UA62996C2 (en) 2004-01-15
NZ506234A (en) 2003-05-30
AU3299099A (en) 1999-09-15
BR9908325A (pt) 2000-11-07
CA2320448A1 (fr) 1999-09-02
WO1999043676A3 (fr) 1999-10-21
KR100568658B1 (ko) 2006-04-07
AU748178B2 (en) 2002-05-30
DE69918062D1 (de) 2004-07-22
OA11480A (en) 2004-05-05
IL138044A0 (en) 2001-10-31
DE69918062T2 (de) 2005-06-02
HUP0100931A3 (en) 2002-08-28
ES2219038T3 (es) 2004-11-16

Similar Documents

Publication Publication Date Title
NO20004281L (no) 6,9-disubstituerte 2-[trans-(4-aminocykloheksyl)amino]puriner, farmasoytisk preparat inneholdende disse, og anvendelse derav for fremstilling av et medikament
CA2320474A1 (fr) 2-[trans-(4-aminocyclohexyl)amino]purines 6,9-disubstituees
NO20020391L (no) 8-Fenyl-6,9-dihydro-[1,2,4]-triazolo [3,4-i]-purin-5-on- derivater
DK1406876T3 (da) 2-anilinopyrimidinderivater som inhibitorer af cyclinafhængige kinaser
NO20061660L (no) 2-pyridonderivate som neutrofil elasaeinhibitor og deres anvendelse
NO20045099L (no) Peptid-derivater omfattende tiazepingruppen for behandling av hyperlipidemiske tilstander
NO20061700L (no) 2-pyridonderivater som neutrofil elastase inhibitorer og deres anvendelse
NO20063931L (no) Nye sammensetninger inneholdende kinolinforbindelser
NO20044599L (no) 3-amino-tieno[2,3-b]pyridin-2-karboksysyreamid-forbindelser og fremgangsmater for fremstilling og anvendelser av dem
NO20063231L (no) Pyrido[2,3-D]pyrimidin-2,4-diaminer som PDE 2 inhibitorer
NO20053133L (no) Kjemiske forbindelser.
NO20043851L (no) Derivater av 4-(imidazol-5-yl)-2-(4-sulfoanilino) pyrimidin med CDK inhibitorisk aktivitet
NO983493L (no) Nye benzimidazol-, benzoksazol- og benzotiazolforbindelser, fremgangsmÕte ved fremstilling derav og farmas°ytiske sammensetninger inneholdende slike
NO20004089L (no) Nye triazolo(4,5-d)pyrimidinforbindelser
JPH0317080A (ja) 置換ピリドピリミジン誘導体
NO994900L (no) Forbindelser
NO160297C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-oksoazetidinderivater
NO20023001L (no) Substituerte piperazinderivater som MTP inhibitorer
NO20026081L (no) Nye forbindelser
NO982072L (no) Amidin- og isotioureaderivater som inhibitorer av nitrogenoksydsyntase
NO20045132L (no) Benzo(c)kinolizinderivater, deres fremstilling og anvendelse som 5alfa- reduktaseinhibitorer
NO992731D0 (no) Nye substituerte tetrahydropyridinforbindelser, fremgangsmÕte ved fremstilling av dem og farmas°ytiske sammensetninger derav
SE0202461D0 (sv) Novel compounds
TR199902720T2 (xx) Nitrik oksit sentaz�n�n inhibit�rleri olarak amidin t�revleri.
NO20041761L (no) Nye hydroksyalkylindolokarbazolforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application